Panacea Global Presents Its Cancer Diagnostic Technology at the World Cancer Congress in Melbourne, Australia
Marketwired - Fri Dec 05, 11:44AM CST
Panacea Global, Inc. ("Panacea"
Panacea Global Invited to Present Its Cancer Diagnostics Technology at the 2nd Global Life Sciences Conference in Warsaw, Poland
Marketwire - Fri Oct 03, 9:22AM CDT
Panacea Global, Inc. ("Panacea"
SeeThruEquity Initiates Research Coverage on Panacea Global, Inc. with a Target Price of $0.82
ACCESSWIRE - Tue Sep 30, 7:34AM CDT
New York, NY / ACCESSWIRE / September 30, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on Panacea Global, Inc. (OTC: PANG), a development stage biopharmaceutical company focused on the development and commercialization of diagnostic products for the management of cancer.